Number of employees ~ 500 (2014) Founded 1992 | Headquarters Laval Type of business Private | |
Industry Contract Research Organization
Pharmaceutical
Biotechnology Key people Christopher Perkin, CEO Products Support services for Pharmaceutical and Biotech industries Profiles | ||
Algorithme Pharma, a member of Altasciences, is an established early stage Clinical Contract Research Organization (CRO) providing research services for pharmaceutical, biotechnology and generic drug industries. The corporation is a full service provider offering Bioanalysis, Data Management, Biostatistics, Regulatory Support, Clinical Pharmacology and Project Management.
Contents
Location
Algorithme Pharma’s headquarters are located in Laval (Quebec, Canada) and include a 20,000-square-foot Bioanalytical Laboratory. The Montreal, Québec, clinic offers 265 beds, while Fargo, North Dakota, clinic has access to 200. The beds are located in fully equipped clinical units, including a dedicated long-stay unit. Their sister company, Vince & Associates Clinical Research, is located in Overland Park, Kansas, USA, and offers 100 beds.
History
Algorithme Pharma was founded in 1992 by a small team of researchers from the pharmacology department of the Université de Montréal and is the largest privately held Québec-owned organization specializing in clinical research services for the international pharmaceutical industry. After more than 20 years in business, the company conducts over 200 clinical trials annually in Phase I/IIa, Bioequivalence and Bioanalysis (preclinical to Phase I-IV) with the participation of over 5,000 participants. Today, their team is made up of close to 500 professionals from the medical and scientific fields who work together to service a global clientele and contribute to the advancement of pharmaceutical science.
At a Glance
Regulatory Authorities
Its Canadian facilities were successfully audited by the U.S. Food and Drug Administration (FDA), Canadian Therapeutic Products Directorate (TPD), Brazilian ANVISA, French ANSM, UK MHRA, Austrian AGES, Thai Ministry of Public Health and the Spanish AEMPS regulatory authorities.